newsfilter
← Latest News
GlobeNewswire·

ReShape Lifesciences® Enters into Warrant Exercise Transaction for $1.2 Million in Gross Proceeds

IRVINE, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences, Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health solutions company, announced today that it has entered into a